Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding

被引:169
作者
Rosenberg, MF
Kamis, AB
Callaghan, R
Higgins, CF
Ford, RC [1 ]
机构
[1] Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Clin Lab Sci, Oxford OX3 9DU, England
[3] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci, London W12 0NN, England
关键词
D O I
10.1074/jbc.M211758200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoprotein is an ATP-binding cassette transporter that is associated with multidrug resistance and the failure of chemotherapy in human patients. We have previously shown, based on two-dimensional projection maps, that P-glycoprotein undergoes conformational changes upon binding of nucleotide to the intracellular nucleotide binding domains. Here we present the three-dimensional structures of P-glycoprotein in the presence and absence of nucleotide, at a resolution limit of similar to2 nm, determined by electron crystallography of negatively stained crystals. The data reveal a major reorganization of the transmembrane domains throughout the entire depth of the membrane upon binding of nucleotide. In the absence of nucleotide, the two transmembrane domains form a single barrel 5-6 nm in diameter and about 5 nm deep with a central pore that is open to the extracellular surface and spans much of the membrane depth. Upon binding nucleotide, the transmembrane domains reorganize into three compact domains that are each 2-3 nm in diameter and 5-6 nm deep. This reorganization opens the central pore along its length in a manner that could allow access of hydrophobic drugs (transport substrates) directly from the lipid bilayer to the central pore of the transporter.
引用
收藏
页码:8294 / 8299
页数:6
相关论文
共 45 条
[21]   Crystal structure of the ATP-binding subunit of an ABC transporter [J].
Hung, LW ;
Wang, IXY ;
Nikaido, K ;
Liu, PQ ;
Ames, GFL ;
Kim, SH .
NATURE, 1998, 396 (6712) :703-707
[22]   Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity [J].
Julien, M ;
Gros, P .
BIOCHEMISTRY, 2000, 39 (15) :4559-4568
[23]   Structure and association of ATP-binding cassette transporter nucleotide-binding domains [J].
Kerr, ID .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1561 (01) :47-64
[24]   Projection structure of P-glycoprotein by electron microscopy - Evidence for a closed conformation of the nucleotide binding domains [J].
Lee, JY ;
Urbatsch, IL ;
Senior, AE ;
Wilkens, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :40125-40131
[25]   The Escherichia coli ATP-binding cassette (ABC) proteins [J].
Linton, KJ ;
Higgins, CF .
MOLECULAR MICROBIOLOGY, 1998, 28 (01) :5-13
[26]   Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains [J].
Liu, RH ;
Sharom, FJ .
BIOCHEMISTRY, 1996, 35 (36) :11865-11873
[27]   Intrinsic fluorescence of the P-glycoprotein multidrug transporter: Sensitivity of tryptophan residues to binding of drugs and nucleotides [J].
Liu, RH ;
Siemiarczuk, A ;
Sharom, FJ .
BIOCHEMISTRY, 2000, 39 (48) :14927-14938
[28]   The E-coli BtuCD structure:: A framework for ABC transporter architecture and mechanism [J].
Locher, KP ;
Lee, AT ;
Rees, DC .
SCIENCE, 2002, 296 (5570) :1091-1098
[29]   Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates [J].
Loo, TW ;
Clarke, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27482-27487
[30]   Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis [J].
Martin, C ;
Berridge, G ;
Mistry, P ;
Higgins, C ;
Charlton, P ;
Callaghan, R .
BIOCHEMISTRY, 2000, 39 (39) :11901-11906